These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 8640984

  • 1. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist.
    Kaddoura S, Firth JD, Boheler KR, Sugden PH, Poole-Wilson PA.
    Circulation; 1996 Jun 01; 93(11):2068-79. PubMed ID: 8640984
    [Abstract] [Full Text] [Related]

  • 2. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload.
    Ito H, Hiroe M, Hirata Y, Fujisaki H, Adachi S, Akimoto H, Ohta Y, Marumo F.
    Circulation; 1994 May 01; 89(5):2198-203. PubMed ID: 8181145
    [Abstract] [Full Text] [Related]

  • 3. Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats.
    Ehmke H, Faulhaber J, Münter K, Kirchengast M, Wiesner RJ.
    Hypertension; 1999 Apr 01; 33(4):954-60. PubMed ID: 10205230
    [Abstract] [Full Text] [Related]

  • 4. Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro.
    Magga J, Vuolteenaho O, Marttila M, Ruskoaho H.
    Circulation; 1997 Nov 04; 96(9):3053-62. PubMed ID: 9386175
    [Abstract] [Full Text] [Related]

  • 5. Endothelin-3 induces hypertrophy of cardiomyocytes by the endogenous endothelin-1-mediated mechanism.
    Tamamori M, Ito H, Adachi S, Akimoto H, Marumo F, Hiroe M.
    J Clin Invest; 1996 Jan 15; 97(2):366-72. PubMed ID: 8567956
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney.
    Benigni A, Zola C, Corna D, Orisio S, Facchinetti D, Benati L, Remuzzi G.
    Am J Kidney Dis; 1996 Mar 15; 27(3):416-23. PubMed ID: 8604712
    [Abstract] [Full Text] [Related]

  • 8. ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats.
    Oie E, Bjønerheim R, Grogaard HK, Kongshaug H, Smiseth OA, Attramadal H.
    Am J Physiol; 1998 Sep 15; 275(3):H868-77. PubMed ID: 9724291
    [Abstract] [Full Text] [Related]

  • 9. Predominant activation of endothelin-dependent cardiac hypertrophy by norepinephrine in rat left ventricle.
    Moser L, Faulhaber J, Wiesner RJ, Ehmke H.
    Am J Physiol Regul Integr Comp Physiol; 2002 May 15; 282(5):R1389-94. PubMed ID: 11959681
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release.
    Leskinen H, Vuolteenaho O, Ruskoaho H.
    Circ Res; 1997 Jan 15; 80(1):114-23. PubMed ID: 8978330
    [Abstract] [Full Text] [Related]

  • 12. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan).
    Teerlink JR, Löffler BM, Hess P, Maire JP, Clozel M, Clozel JP.
    Circulation; 1994 Nov 15; 90(5):2510-8. PubMed ID: 7955209
    [Abstract] [Full Text] [Related]

  • 13. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y, Oliver JR, Horowitz JD.
    Cardiovasc Res; 1998 Sep 15; 39(3):665-73. PubMed ID: 9861310
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure.
    Iwanaga Y, Kihara Y, Inagaki K, Onozawa Y, Yoneda T, Kataoka K, Sasayama S.
    Circulation; 2001 Jul 31; 104(5):606-12. PubMed ID: 11479261
    [Abstract] [Full Text] [Related]

  • 15. Endothelin blockade in angiotensin II hypertension: prevention and treatment studies in the rat.
    Ficai S, Herizi A, Mimran A, Jover B.
    Clin Exp Pharmacol Physiol; 2001 Dec 31; 28(12):1100-3. PubMed ID: 11903325
    [Abstract] [Full Text] [Related]

  • 16. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling.
    Fraccarollo D, Hu K, Galuppo P, Gaudron P, Ertl G.
    Circulation; 1997 Dec 02; 96(11):3963-73. PubMed ID: 9403621
    [Abstract] [Full Text] [Related]

  • 17. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
    Seo B, Oemar BS, Siebenmann R, von Segesser L, Lüscher TF.
    Circulation; 1994 Mar 02; 89(3):1203-8. PubMed ID: 8124808
    [Abstract] [Full Text] [Related]

  • 18. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.
    Richard V, Kaeffer N, Hogie M, Tron C, Blanc T, Thuillez C.
    Br J Pharmacol; 1994 Nov 02; 113(3):869-76. PubMed ID: 7858879
    [Abstract] [Full Text] [Related]

  • 19. Effect of selective ET(A) receptor blockade on natriuretic peptide gene expression in DOCA-salt hypertension.
    Bianciotti LG, De Bold AJ.
    Am J Physiol Heart Circ Physiol; 2000 Jul 02; 279(1):H93-H101. PubMed ID: 10899045
    [Abstract] [Full Text] [Related]

  • 20. Differential remodeling of the left and right heart after norepinephrine treatment in rats: studies on cytokines and collagen.
    Barth W, Deten A, Bauer M, Reinohs M, Leicht M, Zimmer HG.
    J Mol Cell Cardiol; 2000 Feb 02; 32(2):273-84. PubMed ID: 10722803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.